• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠道微生物群在还原药物代谢中的作用。

Gut microbiota in reductive drug metabolism.

机构信息

Department of Pharmaceutical Sciences, Center for Biomolecular Sciences, College of Pharmacy, University of Illinois at Chicago, Chicago, IL, United States.

Department of Pharmaceutical Sciences, Center for Biomolecular Sciences, College of Pharmacy, University of Illinois at Chicago, Chicago, IL, United States.

出版信息

Prog Mol Biol Transl Sci. 2020;171:61-93. doi: 10.1016/bs.pmbts.2020.04.002. Epub 2020 Apr 24.

DOI:10.1016/bs.pmbts.2020.04.002
PMID:32475528
Abstract

Gut bacteria are predominant microorganisms in the gut microbiota and have been recognized to mediate a variety of biotransformations of xenobiotic compounds in the gut. This review is focused on one of the gut bacterial xenobiotic metabolisms, reduction. Xenobiotics undergo different types of reductive metabolisms depending on chemically distinct groups: azo (-NN-), nitro (-NO), alkene (-CC-), ketone (-CO), N-oxide (-NO), and sulfoxide (-SO). In this review, we have provided select examples of drugs in six chemically distinct groups that are known or suspected to be subjected to the reduction by gut bacteria. For some drugs, responsible enzymes in specific gut bacteria have been identified and characterized, but for many drugs, only circumstantial evidence is available that indicates gut bacteria-mediated reductive metabolism. The physiological roles of even known gut bacterial enzymes have not been well defined.

摘要

肠道细菌是肠道微生物群中的主要微生物,已被证实可以介导肠道中外源化合物的多种生物转化。这篇综述主要集中于肠道细菌对外源物代谢的一种方式:还原。根据化学结构的不同,外源物会经历不同类型的还原代谢:偶氮(-NN-)、硝基(-NO)、烯烃(-CC-)、酮(-CO)、N-氧化物(-NO)和亚砜(-SO)。在这篇综述中,我们提供了六个化学结构不同的已知或疑似经肠道细菌还原的药物类别中的选择实例。对于某些药物,已鉴定和表征了特定肠道细菌中的相关酶,但对于许多药物,只有间接证据表明肠道细菌介导的还原代谢。甚至已知的肠道细菌酶的生理作用也尚未很好地定义。

相似文献

1
Gut microbiota in reductive drug metabolism.肠道微生物群在还原药物代谢中的作用。
Prog Mol Biol Transl Sci. 2020;171:61-93. doi: 10.1016/bs.pmbts.2020.04.002. Epub 2020 Apr 24.
2
Gut microbiome interactions with drug metabolism, efficacy, and toxicity.肠道微生物群与药物代谢、疗效及毒性的相互作用。
Transl Res. 2017 Jan;179:204-222. doi: 10.1016/j.trsl.2016.08.002. Epub 2016 Aug 13.
3
Chemical transformation of xenobiotics by the human gut microbiota.人类肠道微生物群对外源化合物的化学转化。
Science. 2017 Jun 23;356(6344). doi: 10.1126/science.aag2770.
4
Chemical Metabolism of Xenobiotics by Gut Microbiota.肠道微生物对外源化学物质的化学代谢。
Curr Drug Metab. 2020;21(4):260-269. doi: 10.2174/1389200221666200303113830.
5
Human gut microbiota plays a role in the metabolism of drugs.人类肠道微生物群在药物代谢中发挥作用。
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2016 Sep;160(3):317-26. doi: 10.5507/bp.2016.039. Epub 2016 Aug 2.
6
Identification of Gut Bacterial Enzymes for Keto-Reductive Metabolism of Xenobiotics.鉴定肠道细菌酶在异生物质酮还原代谢中的作用。
ACS Chem Biol. 2022 Jul 15;17(7):1665-1671. doi: 10.1021/acschembio.2c00312. Epub 2022 Jun 10.
7
Drug Metabolism by the Host and Gut Microbiota: A Partnership or Rivalry?宿主与肠道微生物群的药物代谢:合作还是竞争?
Drug Metab Dispos. 2015 Oct;43(10):1499-504. doi: 10.1124/dmd.115.065714. Epub 2015 Aug 10.
8
A novel approach for the prediction of species-specific biotransformation of xenobiotic/drug molecules by the human gut microbiota.一种通过人类肠道微生物预测异源生物/药物分子种属特异性生物转化的新方法。
Sci Rep. 2017 Aug 29;7(1):9751. doi: 10.1038/s41598-017-10203-6.
9
Multimodal interactions of drugs, natural compounds and pollutants with the gut microbiota.药物、天然化合物和污染物与肠道微生物群的多模式相互作用。
Nat Rev Microbiol. 2022 Jul;20(7):431-443. doi: 10.1038/s41579-022-00681-5. Epub 2022 Jan 31.
10
Gut Microbiota-Mediated Drug-Antibiotic Interactions.肠道微生物群介导的药物-抗生素相互作用
Drug Metab Dispos. 2015 Oct;43(10):1581-9. doi: 10.1124/dmd.115.063867. Epub 2015 Apr 29.

引用本文的文献

1
Computational analysis of the gut microbiota-mediated drug metabolism.肠道微生物群介导的药物代谢的计算分析。
Comput Struct Biotechnol J. 2025 Mar 11;27:1472-1481. doi: 10.1016/j.csbj.2025.03.016. eCollection 2025.
2
Dynamic Shifts in Antibiotic Residues and Gut Microbiome Following Tilmicosin Administration to Silkie Chickens.给丝羽乌骨鸡施用替米考星后抗生素残留和肠道微生物群的动态变化
Animals (Basel). 2024 Nov 27;14(23):3428. doi: 10.3390/ani14233428.
3
Microbial metabolism marvels: a comprehensive review of microbial drug transformation capabilities.
微生物代谢的奇迹:微生物药物转化能力的综合评述。
Gut Microbes. 2024 Jan-Dec;16(1):2387400. doi: 10.1080/19490976.2024.2387400. Epub 2024 Aug 16.
4
Dissecting CYP1A2 Activation by Arylalkanoic Acid Prodrugs toward the Development of Anti-Inflammatory Agents.剖析芳烷酸前药对 CYP1A2 的激活作用,以开发抗炎药物。
Int J Mol Sci. 2023 Dec 28;25(1):435. doi: 10.3390/ijms25010435.
5
Application of artificial intelligence approaches to predict the metabolism of xenobiotic molecules by human gut microbiome.应用人工智能方法预测人类肠道微生物群对外源生物分子的代谢。
Front Microbiol. 2023 Dec 5;14:1254073. doi: 10.3389/fmicb.2023.1254073. eCollection 2023.
6
The pyridazine heterocycle in molecular recognition and drug discovery.哒嗪杂环在分子识别与药物发现中的应用
Med Chem Res. 2023 Mar 15:1-69. doi: 10.1007/s00044-023-03035-9.
7
Human Gut Microbiota and Drug Metabolism.人体肠道微生物群与药物代谢。
Microb Ecol. 2023 Jul;86(1):97-111. doi: 10.1007/s00248-022-02081-x. Epub 2022 Jul 23.
8
Toxicity, outcome, and management of anthracycline overdoses in 16 dogs.16 只狗的蒽环类药物过量的毒性、结果和处理。
J Vet Intern Med. 2022 Jan;36(1):234-243. doi: 10.1111/jvim.16325. Epub 2021 Nov 25.
9
Novel advances in biotransformation and bioactivation research - 2020 year in review.生物转化和生物活化研究的新进展——2020 年回顾。
Drug Metab Rev. 2021 Aug;53(3):384-433. doi: 10.1080/03602532.2021.1916028. Epub 2021 Jun 24.
10
Quantification and Metabolite Identification of Sulfasalazine in Mouse Brain and Plasma Using Quadrupole-Time-of-Flight Mass Spectrometry.采用四极杆飞行时间质谱法对小鼠脑和血浆中的柳氮磺胺吡啶进行定量和代谢产物鉴定。
Molecules. 2021 Feb 22;26(4):1179. doi: 10.3390/molecules26041179.